Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions

Bone Marrow Transplantation

Volumn 38, Issue 3, 2006, Pages 229-235

  Giordano, F A ^a   Fehse, B ^b   Hotz Wagenblatt, A ^a   Jonnakuty, S ^a   del Val, C ^a   Appelt, J U ^a   Nagy, K Z ^a   Kuehlcke, K ^c   Naundorf, S ^c   Zander, A R ^b   Zeller, W J ^a   Ho, A D ^d   Fruehauf, Stefan ^d   Laufs, S ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c BIONTECH AG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KANAMYCIN KINASE; NUCLEIC ACID; RECEPTOR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DONOR LYMPHOCYTE INFUSION; GENE MAPPING; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN GENOME; IMMUNOTHERAPY; IN VITRO STUDY; LEUKEMIA; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUICIDE GENE; SUICIDE GENE THERAPY; T LYMPHOCYTE; TARGET CELL; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE;

ANIMALS; ATTACHMENT SITES, MICROBIOLOGICAL; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA VIRUS, MURINE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SIMPLEXVIRUS; T-LYMPHOCYTES; VIRUS INTEGRATION;

EID: 33746318090     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705424     Document Type: Article

References (30)

1. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996; 2: 551-555.
2. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for blood and marrow transplantation working party chronic leukemia. Blood 1995; 86: 2041-2050.
3. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 1993; 328: 593-602.
4. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: An approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 1994; 84: 1333-1341.
5. Bordignon C, Bonini C, Verzeletti S, Nobili N, Maggioni D, Traversari C et al. Transfer of the HSV-TK gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther 1995; 6: 813-819.
6. Tiberghien P, Cahn JY, Brion A, Deconinck E, Racadot E, Herve P et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: A phase I-II study. Hum Gene Ther 1997; 8: 615-624.
7. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
8. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, Von Kalle C, Meyer J et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.
9. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255-256.
10. Recchia A, Bonini C, Magnani Z, Urbinati F, Sartori D, Muraro S et al. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci USA 2006; 103: 1457-1462.
11. Giordano FA, Hotz-Wagenblatt A, Lauterborn D, Appelt J-U, Fellenberg K, Nagy KZ et al. New bioinformatic strategies to rapidly characterize retroviral integration sites (submitted).
12. Jonnakuty S, del Val C, Glatting KH, Suhai S. ExpressMiner: A tool for mining the gene expression data from microarray experiments. 12th International Conference on Intelligent Systems for Molecular Biology (ISMB 2004) and third European Conference on Computational Biology (ECCB 2004), Glasgow, Scotland, UK.
13. Frank O, Rudolph C, Heberlein C, von Neuhoff N, Schrock E, Schambach A et al. Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 2004; 104: 3543-3549.
14. Kuhlcke K, Ayuk FA, Li Z, Lindemann C, Schilz A, Schade UM et al. Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation. Bone Marrow Transplant 2000; 25: S96-S98.
15. +-enriched blood stem cells. Blood 2004; 104: 3408-3409.
16. Laufs S, Gentner B, Nagy KZ, Jauch A, Benner A, Naundorf S et al. Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 2003; 101: 2191-2198.
17. Burge C, Karlin S. Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997; 268: 78-94.
18. Pruitt KD, Maglott DR. RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res 2001; 29: 137-140.
19. Schuler GD. Pieces of the puzzle: Expressed sequence tags and the catalog of human genes. J Mol Med 1997; 75: 694-698.
20. Bairoch A, Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res 2000; 28: 45-48.
21. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
22. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29.
23. Kuehlcke K, Naundorf S, Laufs S, Fauser AA, Fruehauf S. Optimising retroviral-mediated gene transfer into hematopoietic stem cells under clinically relevant conditions. Blood 2002; 100: 484B-485B.
24. De Palma M, Montini E, Santoni de Sio FR, Benedicenti F, Gentile A, Medico E et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 2004; 105: 2307-2315.
25. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002; 110: 521-529.
26. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2004; 2: E234.
27. Wu XL, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751.
28. Laufs S, Nagy KZ, Giordano F, Hotz-Wagenblatt A, Zeller WJ, Fruehauf S. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns. Mol Ther 2004; 10: 874-881.
29. Gentner B, Laufs S, Nagy KZ, Zeller WJ, Fruehauf S. Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primers. Gene Therapy 2003; 10: 789-794.
30. Nagy KZ, Laufs S, Gentner B, Naundorf S, Kuehlcke K, Topaly J et al. Clonal analysis of individual marrow-repopulating cells after experimental peripheral blood progenitor cell transplantation. Stem Cells 2004; 22: 570-579.